Maurya SK, Gollapalli DR, Kirubakaran S, et al. Triazole inhibitors of Cryptosporidium parvum inosine 5’-monophosphate dehydrogenase.
[3]
Sassetti CM, Boyd DH, Rubin EJ. Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol, 2003, 48(1):77-84.
J Med Chem, 2009, 52:4623-4630.
[4]
Shu Q, Nair V. Inosine monophosphate dehydrogenase (IMPDH) as a
target in drug discovery. Med Res Rev, 2008, 28(2):219-232.
[5]
Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 1998, 393(6685):537-544.
[7]
Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening
assays. J Biomol Screen, 1999, 4(2):67-73.
[9]
Umejiego NN, Gollapalli D, Sharling L, et al. Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis. Chem Rev, 2008, 15(1):70-77.
2011, Vol. 6 
